Skip to content
Home/GPs/UI Investissement
UI Investissement

UI Investissement

UI Investissement is an independent French private-equity manager born in 1967 within Credit Agricole and spun out as an independent house in 2004. From Paris and more than ten regional offices it backs unlisted French SMEs and mid-caps nationwide across development capital, LBO/transmission and innovation (deeptech and health) strategies, having supported over 600 companies with roughly 1.7bn euros under management. It scaled by absorbing regional and sector players including IRPAC, Invest PME, Sofimac, Kreaxi and FNB Private Equity, and runs specialised vehicles such as the Pertinence Invest deeptech funds, the Majycc health fund, the Cap Autrement impact fund and the FNB Europe agrifood funds.

AUM
€1.7B
Funds
4
vintages 2005–2023
Portfolio
36
Exits
3

Key facts

HQParis, France
Founded1967
Employees80+

Recent exits

Amolyt Pharma
Amolyt Pharma
Biotech2024 · 9yr hold
Mablink
Biotech2023 · 2yr hold
Almaviva Sante
Healthcare2017 · 4yr hold

Coverage notes

4 funds tracked, 39 portfolio companies (36 active · 3 realized). Verified weekly from public filings and deal announcements.

Sector breakdown

39 companies
Consumer
6 · 15%
MedTech
5 · 13%
Industrials
4 · 10%
HealthTech
3 · 8%
Biotech
3 · 8%
ClimateTech
3 · 8%
Energy
2 · 5%
Healthcare
2 · 5%

Funds & portfolio

Every fund UI Investissement has raised, with its portfolio companies. Hand-checked from public filings.

4 funds
Cap AutrementGrowth
2023 · 3yr3 active

Unrealized

3 held
AgriwattActive
EnergyFrance· Entry 2023
TMTFrance· Entry 2023
Groupe VITActive
IndustrialsFrance· Entry 2024
FNB Europe Fund IGrowth
2022 · 4yr1 active

Unrealized

1 held
Mousline
MouslineActive
ConsumerFrance· Entry 2022
Majycc Innovation SanteGrowthHarvesting
2019 · 7yr3 active

Unrealized

3 held
Gleamer
GleamerActive
HealthTechFrance· Entry 2023
Lifen
LifenActive
HealthTechFrance· Entry 2019
Naox
NaoxActive
HealthTechFrance· Entry 2021
UI InvestissementGrowthHarvesting
2005 · 21yr29 active · 3 realized

Unrealized

29 held
365 Talents
365 TalentsActive
HR TechFrance· Entry 2018
Acolad
AcoladActive
Business ServicesFrance· Entry 2020
Acusurgical
AcusurgicalActive
MedTechFrance· Entry 2021
Deep TechFrance· Entry 2024
AdEchoTechActive
MedTechFrance· Entry 2024
AI/MLFrance· Entry 2021
Anozr Way
Anozr WayActive
CybersecurityFrance· Entry 2021
MedTechFrance· Entry 2022
Atawey
AtaweyActive
EnergyFrance· Entry 2025
Avanteam
AvanteamActive
SoftwareFrance· Entry 2022
BobineActive
ClimateTechFrance· Entry 2026
BiotechFrance· Entry 2024
Cardiawave
CardiawaveActive
MedTechFrance· Entry 2015
Daco Bello
Daco BelloActive
ConsumerFrance· Entry 2019
Diabeloop
DiabeloopActive
MedTechFrance· Entry 2017
DomusVi
DomusViActive
HealthcareFrance· Entry 2021
EkkiaActive
ConsumerFrance· Entry 2005
ConsumerFrance· Entry 2025
IndustrialsFrance· Entry 2015
Kaviari
KaviariActive
ConsumerFrance· Entry 2026
La Boucherie
La BoucherieActive
HospitalityFrance· Entry 2017
LeddarTechActive
MobilityCanada· Entry 2021
IndustrialsFrance· Entry 2017
ConsumerFrance· Entry 2019
Materrup
MaterrupActive
ClimateTechFrance· Entry 2020
Mecaware
MecawareActive
ClimateTechFrance· Entry 2021
MinelecActive
IndustrialsFrance· Entry 2026
PharmaFrance· Entry 2026
SOLIA
SoliaActive
DiversifiedFrance· Entry 2016

Realized

3 exits
Almaviva SanteExited 2017
HealthcareFrance· Entry 2013
Trade Saleto
Amolyt Pharma
Amolyt PharmaExited 2024
BiotechFrance· Entry 2015
Trade Saleto
MablinkExited 2023
BiotechFrance· Entry 2021
Trade Saleto
Track UI Investissement

Saved GPs appear in your watchlist, one click from your workspace.

About UI Investissement

UI Investissement is a French venture capital firm headquartered in Paris with €1.5 billion of assets under management as of December 2024. Founded in 1998, the firm deploys institutional capital across early-stage and selective growth-stage equity rounds in European technology companies, with sector focus spanning healthcare, consumer, industrials, business services and energy.

Investment thesis

UI Investissement targets European and selectively global early-stage and growth-stage technology companies across healthcare, consumer, industrials, business services and energy, deploying institutional venture capital across seed, Series A and Series B rounds. The firm emphasises hands-on operational support during the post-investment value-creation phase, leveraging founder and operator partners alongside institutional capital to support international expansion and category leadership across France and selectively across Europe. Average equity tickets vary by stage with reserve capital preserved for follow-on rounds across the platform.

Recent activity

Recent realised exits include Asia (diversified sectors, 2026), Solia (diversified sectors, 2025), CHOCOLATINE (software, 2025) and OLYMPIADES (software, 2025). The platform tracks 2 fund vehicles, 304 active portfolio companies and 30 realised exits across the strategy's history. Detailed buyer names and multiple data available on Pro at €29/month.

Get the full picture on UI Investissement.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Save this GP to your watchlist
Saved searches that re-run your sourcing filters in one click
Geography breakdown across 2 geographies
Exit buyers and MOIC on every realized deal (Pro)
Export, compare GPs side by side (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Last updated August 2026 · Sourced from public filings · Report an issue